161 related articles for article (PubMed ID: 18823736)
1. Acute multi-vessel coronary stent thrombosis.
Lawrence MW; Matteucci MJ; Carter LI; Shepherd MS
J Emerg Med; 2011 Sep; 41(3):e43-8. PubMed ID: 18823736
[TBL] [Abstract][Full Text] [Related]
2. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
Bhatt SH; Hauser TH
Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
[TBL] [Abstract][Full Text] [Related]
3. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
4. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
[TBL] [Abstract][Full Text] [Related]
5. Very late bare-metal stent thrombosis. A case report and review of the literature.
Manjappa N; Agarwal A; Cavusoglu E
J Invasive Cardiol; 2006 Jul; 18(7):E203-6. PubMed ID: 16816449
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
7. Stent thrombosis in the era of drug eluting stents.
Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
[TBL] [Abstract][Full Text] [Related]
8. High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients.
Tavassoli N; Voisin S; Carrie D; Lapeyre-Mestre M; Galinier M; Montastruc JL; Pathak A
Am J Cardiovasc Drugs; 2010; 10(1):29-35. PubMed ID: 20104932
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and management of patients with acute or subacute coronary in-stent thrombosis].
Han YL; Liang M; Jing QM; Wang SL; Ma YY; Luan B
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Nov; 34(11):975-8. PubMed ID: 17288755
[TBL] [Abstract][Full Text] [Related]
10. Coronary artery stents: II. Perioperative considerations and management.
Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
[TBL] [Abstract][Full Text] [Related]
11. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL
J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833
[TBL] [Abstract][Full Text] [Related]
12. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].
Silber S; Richartz BM; Brilmayer M;
Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646
[TBL] [Abstract][Full Text] [Related]
13. Late bare metal stent thrombosis.
Oduncu V; Erkol A; Tanboğa IH; Kırma C
Turk Kardiyol Dern Ars; 2010 Sep; 38(6):422-5. PubMed ID: 21200123
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous subacute stent thrombosis of two drug-eluting stents in the left anterior descending and the circumflex coronary arteries. Case report and review of the literature.
Movahed MR; Vu J; Ahsan C
J Invasive Cardiol; 2006 Jul; 18(7):E198-202. PubMed ID: 16816448
[TBL] [Abstract][Full Text] [Related]
15. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
[TBL] [Abstract][Full Text] [Related]
16. Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation.
Eshtehardi P; Windecker S; Cook S; Billinger M; Togni M; Garachemani A; Meier B; Hess OM; Wenaweser P
Am Heart J; 2010 May; 159(5):891-898.e1. PubMed ID: 20435201
[TBL] [Abstract][Full Text] [Related]
17. Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
Rossini R; Angiolillo DJ; Musumeci G; Scuri P; Invernizzi P; Bass TA; Mihalcsik L; Gavazzi A
Am J Cardiol; 2008 Mar; 101(6):786-9. PubMed ID: 18328841
[TBL] [Abstract][Full Text] [Related]
18. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
Garg P; Mauri L
Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
Spinler SA
Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
[TBL] [Abstract][Full Text] [Related]
20. Late coronary stent thrombosis.
Thuesen L; Holm NR
Minerva Med; 2010 Feb; 101(1):25-33. PubMed ID: 20228718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
